WHWK - Whitehawk Therapeutics, Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 2.0 0.11 (5.5%) | --- | --- | --- | --- | 0.11 (5.5%) | -0.02 (-0.96%) | -0.02 (-0.96%) |
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
AfterHours
Earnings & Ratios
- Basic EPS:
- -0.76
- Diluted EPS:
- -0.76
- Basic P/E:
- -2.7763
- Diluted P/E:
- -2.7763
- RSI(14) 1m:
- 76.79
- VWAP:
- 2.1
- RVol:
- 0.9551
Events
| Period | Kind | Movement | Occurred At |
|---|